VICTOR CARRERAS: Open Payments
NPI 1730668013 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,435 in 119 payments from 21 companies in 2025. Trend: 2023 $1,495 · 2024 $2,726 · 2025 $2,435
Food & beverage: $2,435
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $334 |
| ABBVIE INC. | 21 | $331 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $242 |
| AstraZeneca Pharmaceuticals LP | 9 | $235 |
| Lilly USA, LLC | 13 | $222 |
| Abbott Laboratories | 11 | $179 |
| Exact Sciences Corporation | 5 | $163 |
| Sumitomo Pharma America, Inc. | 6 | $148 |
| Astellas Pharma US Inc | 5 | $131 |
| Axsome Therapeutics, Inc. | 3 | $101 |
Products named: JARDIANCE, VRAYLAR, Ozempic, FREESTYLE LIBRE 3, GEMTESA, Veozah, Auvelity, MOUNJARO.
Industry payments across MA — which companies pay providers there.
